Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Innate Immunity
|
May 23, 2021
Hypoxia-Inducible Factor 1 Alpha Is Dispensable for Host Defense of Group B Streptococcus Colonization and Infection
Gregory R Lum, Vicki Mercado, Diede van Ens, et al.
The European Physical Journal. E, Soft Matter
|
May 16, 2022
Actomyosin contractility requirements and reciprocal cell-tissue mechanics for cancer cell invasion through collagen-based channels
Lianne Beunk, Gert-Jan Bakker, Diede van Ens, et al.
Current Protocols
|
January 13, 2026
Generation of In Vivo-Inspired 3D Collagen Models for Guided Tumor Invasion In Vitro
Stijn den Daas, Gert-Jan Bakker, Diede van Ens, et al.
Stem Cell Reports
|
November 8, 2024
Interleukin-1β induces trained innate immunity in human hematopoietic progenitor cells in vitro
Daniela Flores-Gomez, Willemijn Hobo, Diede van Ens, et al.
Bone Marrow Transplantation
|
June 13, 2020
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
Diede van Ens, Charlotte M Mousset, Tim J A Hutten, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 20, 2023
Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivo
Jesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.
Cancer Immunology, Immunotherapy : CII
|
April 2, 2021
Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, et al.
Transplantation and Cellular Therapy
|
December 1, 2025
Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8<sup>+</sup> T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
Jesper van Eck van der Sluijs, Diede van Ens, Ayla Grotens, et al.
Brain, Behavior, & Immunity - Health
|
June 13, 2025
Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trial
Anna Ubink, Marieke R Ten Tusscher, Hans J van der Vliet, et al.
Frontiers in Immunology
|
October 8, 2024
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer
Ralph J A Maas, Janneke S Hoogstad-van Evert, Iris M Hagemans, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Innate Immunity
|
May 23, 2021
Hypoxia-Inducible Factor 1 Alpha Is Dispensable for Host Defense of Group B Streptococcus Colonization and Infection
Gregory R Lum, Vicki Mercado, Diede van Ens, et al.
The European Physical Journal. E, Soft Matter
|
May 16, 2022
Actomyosin contractility requirements and reciprocal cell-tissue mechanics for cancer cell invasion through collagen-based channels
Lianne Beunk, Gert-Jan Bakker, Diede van Ens, et al.
Current Protocols
|
January 13, 2026
Generation of In Vivo-Inspired 3D Collagen Models for Guided Tumor Invasion In Vitro
Stijn den Daas, Gert-Jan Bakker, Diede van Ens, et al.
Stem Cell Reports
|
November 8, 2024
Interleukin-1β induces trained innate immunity in human hematopoietic progenitor cells in vitro
Daniela Flores-Gomez, Willemijn Hobo, Diede van Ens, et al.
Bone Marrow Transplantation
|
June 13, 2020
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
Diede van Ens, Charlotte M Mousset, Tim J A Hutten, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 20, 2023
Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivo
Jesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.
Cancer Immunology, Immunotherapy : CII
|
April 2, 2021
Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, et al.
Transplantation and Cellular Therapy
|
December 1, 2025
Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8<sup>+</sup> T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
Jesper van Eck van der Sluijs, Diede van Ens, Ayla Grotens, et al.
Brain, Behavior, & Immunity - Health
|
June 13, 2025
Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trial
Anna Ubink, Marieke R Ten Tusscher, Hans J van der Vliet, et al.
Frontiers in Immunology
|
October 8, 2024
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer
Ralph J A Maas, Janneke S Hoogstad-van Evert, Iris M Hagemans, et al.
Page
of 1